MEHLMAN CONSULTING, INC. for MAYO CLINIC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Quality payments for providers. Accountable care organizations. Clinical laboratory reimbursement. Physician payment policies. S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013. H.R. 2810, SGR Repeal and Medicare Beneficiary Access Act of 2013. Pathway for SGR Reform Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
| CHARLES WOOTERS | — |
| SUSAN ZOOK | — |
Health Issues HCR
General health care. General health reform implementation. Health care value and quality. Drug shortage issues. ICD-10 Implementation. H.R. 3204, the Drug Quality and Security Act. S.959, Pharmaceutical Quality, Security, and Accountability Act, which became P.L. 113-54 on 11/27/13.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
| CHARLES WOOTERS | — |
| SUSAN ZOOK | — |
Medical/Disease Research/Clinical Labs MED
NIH appropriations Clinical laboratory reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
| CHARLES WOOTERS | — |
| SUSAN ZOOK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.